Fresenius Medical Care reports buyback of FMC stock
Published on 10/24/2026 at 10:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWeekend trading and milestones
- Fresenius Medical Care reported the purchase of 849,575 shares on October 19, 2026.
- FMC stock traded at EUR 40.42 at 10:11 a.m. CEST at Lang & Schwarz on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
- Shervin J. Korangy was appointed chief executive officer effective October 12, 2026.
Fresenius Medical Care reported the purchase of 849,575 shares in its buyback program for the period from October 12 through October 16, 2026, according to EQS News. The announcement was published on October 19, 2026.
At Lang & Schwarz, the stock traded in weekend trading at EUR 40.42 on October 24, 2026, with the quote timestamped at 10:11 a.m. CEST.
Weekend trading at Lang & Schwarz
Lang & Schwarz showed a bid of EUR 40.25 and an ask of EUR 40.59 at 10:11 a.m. CEST on October 24, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of FMC stock.
Recent company actions
Fresenius Medical Care said on October 7, 2026, that Shervin J. Korangy would become chief executive officer and chair of the Management Board effective October 12, 2026. He succeeded Helen Giza, who left those roles at the end of October 11, 2026, according to the company’s press release.
Market context: Market report DAX.
Next Xetra session
The next Xetra session is scheduled for October 26, 2026.
